Literature DB >> 9641630

In vitro cellular responses to bioerodible particles loaded with recombinant human bone morphogenetic protein-2.

D A Puleo1, W W Huh, S S Duggirala, P P DeLuca.   

Abstract

Porous 50:50 poly(d,l lactide-co-glycolide) microspheres containing varying amounts of "free" recombinant human bone morphogenetic protein-2 (rhBMP-2) were evaluated for their ability to induce/enhance expression of osteoblastic characteristics by pluripotent mesenchymal cells in vitro. "Free" protein (Fp) is defined as protein present on the surface and within the porous matrix of the microspheres. Four preparations of bioerodible particles (BEP) were used: blank--without rhBMP-2; low Fp--24 microg of free rhBMP-2 per g of particles; medium Fp--403 microg/g; and high Fp--884 microg/g. C3H10T1/2 cells (C3H) and bone marrow stromal cells (BMC) were cultured with 1 mg of BEP for up to 4 weeks, and cell growth and expression of osteogenic responses were determined weekly. For both cell types, control cultures (neither BEP nor rhBMP-2) and cultures with blank BEP exhibited no or minimal osteoblastic characteristics. Compared to control and blank BEP cultures, C3H cells responded to particles having medium and high amounts of free rhBMP-2 with increased cell growth and alkaline phosphatase activity, but osteocalcin secretion and mineralization were not markedly influenced. Low Fp BEP enhanced only the alkaline phosphatase activity of C3H cells. In contrast, although growth was not affected, rhBMP-2-loaded BEP increased alkaline phosphatase activity, osteocalcin secretion, and mineralization in BMC cultures in a dose-dependent manner (i.e., blank < low < medium < high Fp).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9641630     DOI: 10.1002/(sici)1097-4636(199807)41:1<104::aid-jbm13>3.0.co;2-n

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  5 in total

1.  In vitro characterization and in vivo testosterone suppression of 6-month release poly(D,L-lactide) leuprolide microspheres.

Authors:  Byung Ho Woo; Kyu-Heum Na; Bhas A Dani; Ge Jiang; B C Thanoo; Patrick P DeLuca
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

Review 2.  Bioresorbable polymers: heading for a new generation of spinal cages.

Authors:  P I J M Wuisman; T H Smit
Journal:  Eur Spine J       Date:  2005-11-15       Impact factor: 3.134

3.  Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix.

Authors:  B H Woo; B F Fink; R Page; J A Schrier; Y W Jo; G Jiang; M DeLuca; H C Vasconez; P P DeLuca
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

4.  Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model.

Authors:  Zarana S Patel; Simon Young; Yasuhiko Tabata; John A Jansen; Mark E K Wong; Antonios G Mikos
Journal:  Bone       Date:  2008-07-14       Impact factor: 4.398

5.  COMP-angiopoietin1 potentiates the effects of bone morphogenic protein-2 on ischemic necrosis of the femoral head in rats.

Authors:  Lu Zhou; Sun Jung Yoon; Kyu Yun Jang; Young Jae Moon; Sajeev Wagle; Kwang Bok Lee; Byung-Hyun Park; Jung Ryul Kim
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.